Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Incyte: Strong Growth, Margin Expansion, And Low Valuation
11:13pm, Tuesday, 21'st Oct 2025
Incyte Corporation offers strong growth potential and a low valuation, driven by expanding margins and a robust earnings outlook. INCY's revenue is anchored by Jakafi, but a diverse pipeline and poten
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 21'st Oct 2025
Incyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Incyte Corporation (NASDAQ:INCY ) Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic Cancer October 19, 2025 1:30 PM EDT Company Particip
Are You Looking for a Top Momentum Pick? Why Incyte (INCY) is a Great Choice
01:00pm, Monday, 20'th Oct 2025
Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Will Positive Regulatory Updates Further Boost INCY Stock?
10:31am, Monday, 20'th Oct 2025
Incyte's strong 2025 performance is fueled by Jakafi's sustained growth and label expansion of Opzelura.
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ESMO25--Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced CRC and KRAS G12D Inhibitor in Advanced PDAC.
US Bancorp DE Has $1.05 Million Holdings in Incyte Corporation $INCY
04:00am, Saturday, 18'th Oct 2025
US Bancorp DE lifted its position in Incyte Corporation (NASDAQ: INCY) by 5.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The inst
INCY or ARGX: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 16'th Oct 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and argenex SE (ARGX). But which of these two companies is the best option for those looking for
3 Biotech Stocks I Am Accumulating
02:30pm, Wednesday, 15'th Oct 2025
The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good covered call tra
Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000
01:27pm, Tuesday, 14'th Oct 2025
On October 2 and October 3, 2025, Sheila A. Denton, EVP & General Counsel of Incyte (INCY 0.47%), executed an option exercise and immediately sold 4,100 shares of common stock, as disclosed in this SE
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ESMO2025--Data from Incyte's TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the ESMO Congress 2025.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 08'th Oct 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Incyte to Report Third Quarter Financial Results
08:00am, Wednesday, 08'th Oct 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 28, 2
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 07'th Oct 2025
Incyte (INCY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
